Danaher to Acquire Abcam for $24 per Share in $5.7 Billion Deal

SmartCom News APP learned that Danaher (DHR.US) announced it would acquire Abcam (ABCM.US), a UK-based life sciences supplies manufacturer, at a price of $24 per share, outperforming its competitors. Abcam is a UK-headquartered life sciences supplies manufacturer whose technology is utilized by thousands of researchers.

The total value of the deal, including debt and acquisition cash, is approximately $5.7 billion, the two companies said in a statement on Monday. The transaction is expected to be completed by the middle of 2024, and Abcam is expected to operate as an independent company. Danaher plans to fund the acquisition through cash and debt.

Abcam provides scientists with a variety of laboratory products, such as proteins and antibodies used for drug discovery and diagnostics. This acquisition will help Danaher offer full-service solutions to its customers. Danaher is a manufacturer of laboratory equipment and other supplies.